Optimizing Treatment of Antimicrobial-resistant Neisseria gonorrhoeae
The increasing prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae has required replacing inexpensive oral ciprofloxacin treatment with more expensive injectable ceftriaxone. Further, monitoring antimicrobial resistance requires culture testing, but nonculture gonorrhea tests are rapidly rep...
Main Authors: | Kakoli Roy, Susan A. Wang, Martin I. Meltzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2005-08-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/11/8/05-0157_article |
Similar Items
-
Current Trends in Antimicrobial Resistance of Neisseria gonorrhoeae in Russian Federation
by: Kubanov A.A., et al.
Published: (2016-11-01) -
Trends in Neisseria gonorrhoeae Antimicrobial Resistance over a Ten-Year Surveillance Period, Johannesburg, South Africa, 2008–2017
by: Ranmini Kularatne, et al.
Published: (2018-07-01) -
Cephalosporin resistance in Neisseria gonorrhoeae
by: Manju Bala, et al.
Published: (2010-01-01) -
Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae
by: Claire C. Bristow, et al.
Published: (2016-05-01) -
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada
by: I. Martin, et al.
Published: (2016-01-01)